Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1117

1.

Astaxanthin production in a model cyanobacterium Synechocystis sp. PCC 6803.

Shimada N, Okuda Y, Maeda K, Umeno D, Takaichi S, Ikeuchi M.

J Gen Appl Microbiol. 2020 Mar 25. doi: 10.2323/jgam.2020.01.003. [Epub ahead of print]

2.

Pregabalin for postherpetic itch: a case report.

Shimada N, Niwa Y, Hotta K, Igarashi T, Takeuchi M.

JA Clin Rep. 2020 Mar 23;6(1):24. doi: 10.1186/s40981-020-00330-x.

3.

Gelatin Hydrogel-Fragmented Fibers Suppress Shrinkage of Cell Sheet.

Nakamura K, Nobutani K, Shimada N, Tabata Y.

Tissue Eng Part C Methods. 2020 Mar 23. doi: 10.1089/ten.tec.2019.0348. [Epub ahead of print]

PMID:
32202972
4.

[Bone Marrow Metastases of Breast Cancer Treated with Endocrine Therapy-A Case Report].

Okamoto A, Saito A, Konishi M, Shimada N, Matsuo Y, Sugitani Y, Soyama M.

Gan To Kagaku Ryoho. 2019 Dec;46(13):2583-2585. Japanese.

PMID:
32157006
5.

The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study.

Nozaki A, Atsukawa M, Kondo C, Toyoda H, Chuma M, Nakamuta M, Uojima H, Takaguchi K, Ikeda H, Watanabe T, Ogawa S, Itokawa N, Arai T, Hiraoka A, Asano T, Fujioka S, Ikegami T, Shima T, Ogawa C, Akahane T, Shimada N, Fukunishi S, Abe H, Tsubota A, Genda T, Okubo H, Mikami S, Morishita A, Moriya A, Tani J, Tachi Y, Hotta N, Ishikawa T, Okanoue T, Tanaka Y, Kumada T, Iwakiri K, Maeda S; KTK49 Liver Study Group.

Hepatol Int. 2020 Mar;14(2):225-238. doi: 10.1007/s12072-020-10019-z. Epub 2020 Mar 3.

PMID:
32128704
6.

Effect of cell seeding methods on the distribution of cells into the gelatin hydrogel nonwoven fabric.

Matsuno K, Saotome T, Shimada N, Nakamura K, Tabata Y.

Regen Ther. 2020 Feb 20;14:160-164. doi: 10.1016/j.reth.2020.01.002. eCollection 2020 Jun. No abstract available.

7.

Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

Hiraoka A, Kumada T, Tada T, Fukunishi S, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Kawata K, Toyoda H, Ohama H, Tsutsui A, Itokawa N, Hayama K, Arai T, Imai M, Nakamura S, Michitaka K, Hiasa Y, Kudo M; Real-Life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group.

Oncology. 2020 Feb 25:1-8. doi: 10.1159/000506293. [Epub ahead of print]

PMID:
32097925
8.

Compression therapy of both hands is safely applicable for the prevention of oxaliplatin-induced neuropathy.

Kawakami K, Koyama Y, Morioka M, Tobaru Y, Sakura Y, Fukumoto M, Nagamine A, Hattori K, Taira I, Shimada N, Okuno E, Tsuyuki S, Kanazawa A.

Ann Oncol. 2019 Jul;30 Suppl 4:iv78-iv79. doi: 10.1093/annonc/mdz155.286. Epub 2019 Dec 4. No abstract available.

PMID:
32085293
9.

Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Hiraoka A, Kumada T, Fukunishi S, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Yokohama K, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K, Kudo M.

Liver Cancer. 2020 Jan;9(1):73-83. doi: 10.1159/000503031. Epub 2019 Oct 18.

10.

Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies.

Kariyama K, Nouso K, Wakuta A, Oonishi A, Toyoda H, Tada T, Hiraoka A, Tsuji K, Itobayashi E, Ishikawa T, Takaguchi K, Tsutsui A, Shimada N, Kumada T.

Liver Cancer. 2020 Jan;9(1):41-49. doi: 10.1159/000502479. Epub 2019 Oct 22.

11.

Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.

Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Yasuda S, Toyoda H, Fukunishi S, Ohama H, Kawata K, Nakamura S, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y.

Liver Int. 2020 Apr;40(4):968-976. doi: 10.1111/liv.14405. Epub 2020 Mar 1.

PMID:
32064740
12.

A retrospective clinical research of relapsed organizing pneumonia.

Yamagishi T, Kodaka N, Watanabe K, Nakano C, Oshio T, Niitsuma K, Shimada N, Matsuse H.

Ann Thorac Med. 2020 Jan-Mar;15(1):15-20. doi: 10.4103/atm.ATM_311_19. Epub 2020 Jan 2.

13.

M1 macrophage infiltration exacerbate muscle/bone atrophy after peripheral nerve injury.

Shimada N, Sakata A, Igarashi T, Takeuchi M, Nishimura S.

BMC Musculoskelet Disord. 2020 Jan 20;21(1):44. doi: 10.1186/s12891-020-3069-z.

14.

Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan.

Toyoda H, Atsukawa M, Watanabe T, Nakamuta M, Uojima H, Nozaki A, Takaguchi K, Fujioka S, Iio E, Shima T, Akahane T, Fukunishi S, Asano T, Michitaka K, Tsuji K, Abe H, Mikami S, Okubo H, Okubo T, Shimada N, Ishikawa T, Moriya A, Tani J, Morishita A, Ogawa C, Tachi Y, Ikeda H, Yamashita N, Yasuda S, Chuma M, Tsutsui A, Hiraoka A, Ikegami T, Genda T, Tsubota A, Masaki T, Iwakiri K, Kumada T, Tanaka Y, Okanoue T.

J Gastroenterol Hepatol. 2020 Jan 16. doi: 10.1111/jgh.14982. [Epub ahead of print]

PMID:
31950525
15.

Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503.

Kubota K, Kunitoh H, Seto T, Shimada N, Tsuboi M, Ohhira T, Okamoto H, Masuda N, Maruyama R, Shibuya M, Watanabe K.

Lung Cancer. 2020 Mar;141:32-36. doi: 10.1016/j.lungcan.2019.11.009. Epub 2019 Nov 29.

PMID:
31931444
16.

Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura.

Nishikawa M, Shimada N, Kawazoe T, Sawaki R, Ikuta H, Kanzaki M, Fukuoka K, Fukushima M, Asano K.

Intern Med. 2020 Apr 1;59(7):983-986. doi: 10.2169/internalmedicine.3837-19. Epub 2019 Dec 20.

17.

DEVELOPMENT OF MACULAR ATROPHY AFTER PARS PLANA VITRECTOMY FOR MYOPIC TRACTION MACULOPATHY AND MACULAR HOLE RETINAL DETACHMENT IN PATHOLOGIC MYOPIA.

Fang Y, Yokoi T, Shimada N, Du R, Shinohara K, Takahashi H, Uramoto K, Ohno-Matsui K.

Retina. 2019 Dec 10. doi: 10.1097/IAE.0000000000002709. [Epub ahead of print]

PMID:
31834131
18.

Total knee arthroplasty for patients with medial knee osteoarthritis improves trunk movement during gait.

Kuwahara W, Nakanishi K, Kurumadani H, Shimada N, Asaeda M, Deie M, Adachi N, Sunagawa T.

J Back Musculoskelet Rehabil. 2019 Nov 22. doi: 10.3233/BMR-181383. [Epub ahead of print]

PMID:
31796661
19.

Synthesis of C12-Keto Saxitoxin Derivatives with Unusual Inhibitory Activity Against Voltage-Gated Sodium Channels.

Adachi K, Yamada T, Ishizuka H, Oki M, Tsunogae S, Shimada N, Chiba O, Orihara T, Hidaka M, Hirokawa T, Odagi M, Konoki K, Yotsu-Yamashita M, Nagasawa K.

Chemistry. 2020 Feb 11;26(9):2025-2033. doi: 10.1002/chem.201904184. Epub 2020 Feb 3.

PMID:
31769085
20.

[The Adverse Effects of Ephedra Herb and the Safety of Ephedrine Alkaloids-free Ephedra Herb Extract (EFE)].

Odaguchi H, Hyuga S, Sekine M, Nakamori S, Takemoto H, Huang X, Oshima N, Shimada N, Yang J, Amakura Y, Hyuga M, Uchiyama N, Kobayashi Y, Hakamatsuka T, Goda Y, Hanawa T.

Yakugaku Zasshi. 2019;139(11):1417-1425. doi: 10.1248/yakushi.19-00122. Review. Japanese.

21.

Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.

Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y.

Hepatol Res. 2020 Jan;50(1):75-83. doi: 10.1111/hepr.13427. Epub 2019 Dec 6.

PMID:
31660700
22.

Cationic copolymer-chaperoned DNAzyme sensor for microRNA detection.

Hanpanich O, Oyanagi T, Shimada N, Maruyama A.

Biomaterials. 2019 Dec;225:119535. doi: 10.1016/j.biomaterials.2019.119535. Epub 2019 Oct 5.

PMID:
31614289
23.

Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.

Toyoda H, Atsukawa M, Watanabe T, Nakamuta M, Uojima H, Nozaki A, Takaguchi K, Fujioka S, Iio E, Shima T, Akahane T, Fukunishi S, Asano T, Michitaka K, Tsuji K, Abe H, Mikami S, Okubo H, Okubo T, Shimada N, Ishikawa T, Moriya A, Tani J, Morishita A, Ogawa C, Tachi Y, Ikeda H, Yamashita N, Yasuda S, Chuma M, Tsutsui A, Hiraoka A, Ikegami T, Genda T, Tsubota A, Masaki T, Tanaka Y, Iwakiri K, Kumada T.

J Gastroenterol Hepatol. 2019 Oct 14. doi: 10.1111/jgh.14874. [Epub ahead of print]

PMID:
31609495
24.

Lung Fixation under Constant Pressure for Evaluation of Emphysema in Mice.

Karasutani K, Baskoro H, Sato T, Arano N, Suzuki Y, Mitsui A, Shimada N, Kodama Y, Seyama K, Fukuchi Y, Takahashi K.

J Vis Exp. 2019 Sep 26;(151). doi: 10.3791/58197.

PMID:
31609316
25.

Cationic copolymer-chaperoned short-armed 10-23 DNAzymes.

Hanpanich O, Miyaguchi H, Huang H, Shimada N, Maruyama A.

Nucleosides Nucleotides Nucleic Acids. 2019 Oct 12:1-14. doi: 10.1080/15257770.2019.1675168. [Epub ahead of print]

PMID:
31608816
26.

Cationic Copolymer-Chaperoned 2D-3D Reversible Conversion of Lipid Membranes.

Shimada N, Kinoshita H, Umegae T, Azumai S, Kume N, Ochiai T, Takenaka T, Sakamoto W, Yamada T, Furuta T, Masuda T, Sakurai M, Higuchi H, Maruyama A.

Adv Mater. 2019 Nov;31(44):e1904032. doi: 10.1002/adma.201904032. Epub 2019 Sep 24.

PMID:
31550402
27.

Effect of piceatannol-rich passion fruit seed extract on human glyoxalase I-mediated cancer cell growth.

Yamamoto T, Sato A, Takai Y, Yoshimori A, Umehara M, Ogino Y, Inada M, Shimada N, Nishida A, Ichida R, Takasawa R, Maruki-Uchida H, Mori S, Sai M, Morita M, Tanuma SI.

Biochem Biophys Rep. 2019 Aug 30;20:100684. doi: 10.1016/j.bbrep.2019.100684. eCollection 2019 Dec.

28.

Donor Site Evaluation After Osteochondral Autograft Transplantation for Capitellar Osteochondritis Dissecans.

Matsuura T, Hashimoto Y, Kinoshita T, Nishino K, Nishida Y, Takigami J, Katsuda H, Shimada N.

Am J Sports Med. 2019 Oct;47(12):2836-2843. doi: 10.1177/0363546519871064. Epub 2019 Sep 10.

PMID:
31503508
29.

Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K; On behalf of the Real-Life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Oncology. 2019;97(6):334-340. doi: 10.1159/000502095. Epub 2019 Aug 29.

PMID:
31466068
30.

FUNCTIONAL AND STRUCTURAL OUTCOMES AFTER FOVEA-SPARING INTERNAL LIMITING MEMBRANE PEELING FOR MYOPIC MACULAR RETINOSCHISIS BY MICROPERIMETRY.

Shinohara K, Shimada N, Takase H, Ohno-Matsui K.

Retina. 2019 Jul 30. doi: 10.1097/IAE.0000000000002627. [Epub ahead of print]

PMID:
31365520
31.

Clinical differentiation of acute appendicitis and right colonic diverticulitis: A case-control study.

Sasaki Y, Komatsu F, Kashima N, Sato T, Takemoto I, Kijima S, Maeda T, Ishii T, Miyazaki T, Honda Y, Shimada N, Urita Y.

World J Clin Cases. 2019 Jun 26;7(12):1393-1402. doi: 10.12998/wjcc.v7.i12.1393.

32.

Total syntheses of seminolipid and its analogues by using 2,6-bis(trifluoromethyl)phenylboronic acid as protective reagent.

Shimada N, Fukuhara K, Urata S, Makino K.

Org Biomol Chem. 2019 Aug 7;17(31):7325-7329. doi: 10.1039/c9ob01445d.

PMID:
31353379
33.

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Tanaka H, Tamai T, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Oncology. 2019;97(5):277-285. doi: 10.1159/000501281. Epub 2019 Jul 15.

PMID:
31307035
34.

Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C.

Kato K, Shimada N, Atsukawa M, Abe H, Itokawa N, Matsumoto Y, Agata R, Tsubota A.

PLoS One. 2019 Jul 10;14(7):e0219022. doi: 10.1371/journal.pone.0219022. eCollection 2019.

35.

Age is an independent predictor in pathological diagnosis of sarcoidosis: a retrospective analysis of diagnosis by endobronchial ultrasound-guided transbronchial needle aspiration.

Kuwasaki E, Nagaoka T, Ihara H, Tsutsumi T, Nakamura A, Yoshikawa H, Yoshida T, Watanabe J, Ichikawa M, Koyama R, Shimada N, Takahashi K.

J Thorac Dis. 2019 May;11(5):2175-2180. doi: 10.21037/jtd.2019.01.94.

36.

Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan.

Ikeda H, Watanabe T, Atsukawa M, Toyoda H, Takaguchi K, Nakamuta M, Matsumoto N, Okuse C, Tada T, Tsutsui A, Yamashita N, Kondo C, Hayama K, Kato K, Itokawa N, Arai T, Shimada N, Asano T, Uojima H, Ogawa C, Mikami S, Ikegami T, Fukunishi S, Asai A, Iio E, Tsubota A, Hiraoka A, Nozaki A, Okubo H, Tachi Y, Moriya A, Oikawa T, Matsumoto Y, Tsuruoka S, Tani J, Kikuchi K, Iwakiri K, Tanaka Y, Kumada T.

J Viral Hepat. 2019 Nov;26(11):1266-1275. doi: 10.1111/jvh.13170. Epub 2019 Aug 9.

PMID:
31278795
37.

Polyethyleneimine-induced astaxanthin accumulation in the green alga Haematococcus pluvialis by increased oxidative stress.

Yoshitomi T, Shimada N, Iijima K, Hashizume M, Yoshimoto K.

J Biosci Bioeng. 2019 Dec;128(6):751-754. doi: 10.1016/j.jbiosc.2019.06.002. Epub 2019 Jun 25.

PMID:
31253510
38.

Can praying mantises escape from spider webs?

Sugiura S, Sakagami K, Harada M, Shimada N.

Ecology. 2019 Nov;100(11):e02799. doi: 10.1002/ecy.2799. Epub 2019 Aug 16. No abstract available.

PMID:
31233620
39.

The Relationship between Knee Biomechanics and Clinical Assessments in ACl Deficient Patients.

Kono Y, Deie M, Fujita N, Hirata K, Shimada N, Orita N, Iwaki D, Asaeda M, Terai C, Kimura H, Adachi N.

Int J Sports Med. 2019 Jul;40(7):477-483. doi: 10.1055/a-0809-5366. Epub 2019 Jun 12.

PMID:
31189191
40.

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Cancer Med. 2019 Jul;8(8):3719-3728. doi: 10.1002/cam4.2241. Epub 2019 May 24.

41.

Trends and Efficacy of Interferon-Free Anti-hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan.

Toyoda H, Atsukawa M, Uojima H, Nozaki A, Tamai H, Takaguchi K, Fujioka S, Nakamuta M, Tada T, Yasuda S, Chuma M, Senoh T, Tsutsui A, Yamashita N, Hiraoka A, Michitaka K, Shima T, Akahane T, Itobayashi E, Watanabe T, Ikeda H, Iio E, Fukunishi S, Asano T, Tachi Y, Ikegami T, Tsuji K, Abe H, Kato K, Mikami S, Okubo H, Shimada N, Ishikawa T, Matsumoto Y, Itokawa N, Arai T, Tsubota A, Iwakiri K, Tanaka Y, Kumada T.

Open Forum Infect Dis. 2019 Apr 15;6(5):ofz185. doi: 10.1093/ofid/ofz185. eCollection 2019 May.

42.

Diboronic Acid Anhydrides as Effective Catalysts for the Hydroxy-Directed Dehydrative Amidation of Carboxylic Acids.

Shimada N, Hirata M, Koshizuka M, Ohse N, Kaito R, Makino K.

Org Lett. 2019 Jun 7;21(11):4303-4308. doi: 10.1021/acs.orglett.9b01484. Epub 2019 May 23.

PMID:
31120259
43.

A Gelatin Hydrogel Nonwoven Fabric Facilitates Metabolic Activity of Multilayered Cell Sheets.

Nakamura K, Saotome T, Shimada N, Matsuno K, Tabata Y.

Tissue Eng Part C Methods. 2019 Jun;25(6):344-352. doi: 10.1089/ten.TEC.2019.0061.

PMID:
31062648
44.

Catalytic Activation of Cis-Vicinal Diols by Boronic Acids: Site-Selective Acylation of Carbohydrates.

Shimada N, Nakamura Y, Ochiai T, Makino K.

Org Lett. 2019 May 17;21(10):3789-3794. doi: 10.1021/acs.orglett.9b01231. Epub 2019 May 6.

PMID:
31058511
45.

Synthesis and Properties of Upper Critical Solution Temperature Responsive Nanogels.

Ohshio M, Ishihara K, Maruyama A, Shimada N, Yusa SI.

Langmuir. 2019 Jun 4;35(22):7261-7267. doi: 10.1021/acs.langmuir.9b00849. Epub 2019 May 7.

PMID:
31035754
46.

Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis.

Hiraoka A, Kumada T, Tsuji K, Takaguchi K, Itobayashi E, Kariyama K, Ochi H, Tajiri K, Hirooka M, Shimada N, Ishikawa T, Tachi Y, Tada T, Toyoda H, Nouso K, Joko K, Hiasa Y, Michitaka K, Kudo M.

Liver Cancer. 2019 Mar;8(2):121-129. doi: 10.1159/000488778. Epub 2018 Jun 11.

47.

Reverse transcription-PCR using a primer set targeting the 3D region detects foot-and-mouth disease virus with high sensitivity.

Nishi T, Kanno T, Shimada N, Morioka K, Yamakawa M, Fukai K.

Transbound Emerg Dis. 2019 Jul;66(4):1776-1783. doi: 10.1111/tbed.13202. Epub 2019 May 13.

PMID:
30973676
48.

Prevalence, development, and factors associated with cyst formation after meniscal repair with the all-inside suture device.

Terai S, Hashimoto Y, Yamasaki S, Takahashi S, Shimada N, Nakamura H.

Arch Orthop Trauma Surg. 2019 Sep;139(9):1261-1268. doi: 10.1007/s00402-019-03176-w. Epub 2019 Apr 9.

PMID:
30968202
49.

Liposome-Surface-Initiated ARGET ATRP: Surface Softness Generated by "Grafting from" Polymerization.

Masuda T, Shimada N, Maruyama A.

Langmuir. 2019 Apr 23;35(16):5581-5586. doi: 10.1021/acs.langmuir.9b00450. Epub 2019 Apr 15.

PMID:
30929438
50.

[A Case of Primary Lymphoma of the Breast with Hepatic Cirrhosis].

Saito A, Okamoto A, Konishi M, Shimada N, Fukunaga M, Sugitani Y, Tanino H, Fukushima T, Oka K.

Gan To Kagaku Ryoho. 2019 Feb;46(2):380-382. Japanese.

PMID:
30914567

Supplemental Content

Loading ...
Support Center